PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.90%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-35.05%
Negative gross profit growth while OBE is at 12.65%. Joel Greenblatt would examine cost competitiveness or demand decline.
507.34%
EBIT growth above 1.5x OBE's 309.68%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
507.34%
Operating income growth above 1.5x OBE's 147.93%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
104.88%
Net income growth at 50-75% of OBE's 195.16%. Martin Whitman would question fundamental disadvantages in expenses or demand.
105.99%
EPS growth at 50-75% of OBE's 191.30%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
105.99%
Diluted EPS growth at 50-75% of OBE's 191.30%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-44.41%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-515.70%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
198.69%
Positive 10Y revenue/share CAGR while OBE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-57.10%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-60.21%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
521.16%
Positive long-term OCF/share growth while OBE is negative. John Neff would see a structural advantage in sustained cash generation.
-61.07%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-65.65%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-83.99%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-97.09%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-98.73%
Negative 3Y CAGR while OBE is 150.88%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
264.25%
10Y equity/share CAGR above 1.5x OBE's 43.60%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-39.66%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-63.04%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
917.44%
Stable or rising dividend while OBE is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
15.72%
Stable or rising mid-term dividends while OBE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-50.06%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-2.77%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while OBE stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-31.54%
Negative asset growth while OBE invests at 0.78%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-48.09%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-5.08%
We’re deleveraging while OBE stands at 5.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.